Large-scale testing (Phase 3)Study completedNCT00086658
What this trial is testing
Intravenous Mepolizumab In Subjects With Hypereosinophilic Syndromes (HES)
Who this might be right for
HypereosinophiliaHypereosinophilic Syndrome
GlaxoSmithKline 86
Showing 6 of 6 results